Immediate Impact

1 by Nobel laureates 4 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2024 Standout
4 intermediate papers

Works of Patrick Sharp being referenced

Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
1998

Author Peers

Author Last Decade Papers Cites
Patrick Sharp 504 231 24 308 241 34 1.0k
Bai‐Chin Lee 158 238 251 174 49 1.2k
Gail Murphy 180 259 2 136 194 23 1.0k
B. Lormeau 262 298 404 128 32 914
Giuseppe Rossi 598 209 173 119 27 1.2k
S Fujioka 260 154 314 130 50 1.2k
Alex Castro 617 413 134 211 47 1.2k
Bengt Isberg 110 162 3 309 206 39 1.1k
J.K. Radder 445 237 2 431 106 33 1.4k
M Leuténegger 294 207 2 269 86 57 1.0k
Cinzia Carrozza 640 536 5 222 49 53 1.2k

All Works

Loading papers...

Rankless by CCL
2026